
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
C9orf84 CRISPR/Cas9 KO Plasmid (h) | sc-406339 | 20 µg | $397.00 | |||
C9orf84 HDR Plasmid (h) | sc-406339-HDR | 20 µg | $445.00 |
C9orf84 (human) encodes a poorly characterized protein with limited functional annotation, but emerging datasets suggest it may participate in fundamental cellular homeostasis pathways, including regulation of gene expression and protein networks linked to proliferation and stress responses. Transcriptomic and proteomic evidence indicates context-dependent expression and potential association with subcellular compartments involved in RNA processing and/or protein turnover. Because C9orf84 remains an understudied open reading frame, perturbation-based approaches are often required to clarify its role in pathway wiring, interaction partners, and phenotypes in relevant cell models. Altered expression patterns reported in multi-omic cancer resources and other disease-focused datasets support its use as a candidate gene for mechanistic studies of dysregulated cellular programs without implying causality.
C9orf84 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the C9orf84 gene in human cell lines. Each plasmid in the pool co-expresses a unique sgRNA, targeting a distinct site within the C9orf84 locus, alongside the Streptococcus pyogenes Cas9 nuclease, and encodes GFP to enable fluorescent identification and enrichment of successfully transfected cells. This multi-guide strategy increases the likelihood of inducing frameshifts or deletions that produce a functional knockout, offering a more robust alternative to single-guide approaches. DSBs induced at multiple sites are resolved through non-homologous end joining (NHEJ) or, when used with the included HDR donor template, homology-directed repair (HDR) at a defined target site within the locus.
When used in conjunction with the RFP-expressing HDR donor, GFP and RFP fluorescence can be used together to distinguish transfected from edited cell populations, streamlining flow cytometry-based sorting and clone selection workflows.
For applications requiring confirmed, selectable knockout clones, C9orf84 HDR Plasmid (h) includes an HDR donor construct containing a puromycin resistance cassette (PuroR) and a red fluorescent protein (RFP) reporter, flanked by homology arms specific to a defined C9orf84 target site.
When co-transfected with C9orf84 CRISPR/Cas9 KO Plasmid (h):
The HDR donor construct features loxP sites flanking the PuroR-RFP selection cassette to allow clean marker removal following clone confirmation. Transient expression of Cre recombinase via the included Cre Vector: sc-418923 excises the cassette, leaving a minimal residual loxP site within the C9orf84 locus and eliminating potential confounding effects on downstream assays.
This two-step approach:
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.